Updated Jul 16, 2026
Borisy Alexis has filed 4 SEC Form 4 filings across 3 companies in the last 90 days.
Alexis Borisy is a prominent figure in the biotechnology sector, known for his role as a director at Blueprint Medicines Corp. He has a background in venture capital and has been involved in various successful biotech ventures.
| Role | Insider |
|---|---|
| Notability | 50/100 |
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-06-23 | RVMD | Revolution Medicines, Inc. | A — Grant or award | 1.2K | $0.00 | |
| 2026-06-15 | PBLS | Parabilis Medicines, Inc. | J — Other acquisition / disposition | 105.4K | — | |
| 2025-07-17 | BPMC | Blueprint Medicines Corp | J — Other acquisition / disposition | 74.2K | — | |
| 2025-07-17 | BPMC | Blueprint Medicines Corp | D — Derivative transaction | 3.9K | — |
Alexis Borisy is a prominent figure in the biotechnology sector, known for his role as a director at Blueprint Medicines Corp. He has a background in venture capital and has been involved in various successful biotech ventures.…
4 primary Form 4 filings in the last 90 days, covering 3 companies.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live Borisy Alexis profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.